Deals this week: Atreca, Calithera Biosciences, Spring Bank Pharmaceuticals
US-based biotechnology company Atreca has secured $35m in a series B financing round led by Wellington Management Company.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals